Re: NAVB is fully funded for RA Dx P3, RA Dx 33-2, CV Dx p2b or 3 (start), pre clinical Thx startup with in house/2 partners....This is a big advancement!!!
Many of us have been around for quite some time. The company is fully funded, as u put it, because it has been diluted exponentially. Neoprobe longs have been absolutely scalped. So forgive me if I’m a lot more guarded than u regarding my excitement. The numbers don’t lie and the share price since Jed Latkin took over is at epic failure levels under anyone’s CEO stewardship standards. It’s time for the elusive P3 start and some real and tangible news. Enough of the rhetoric and fluff from management! And btw, the market isn’t buying the spin either—$2.26.